- Surface modified and rituximab functionalized PAMAM G4 nanoparticle for targeted imatinib delivery to leukemia cells: In vitro studies
Parastoo Fotouhi et al, 2021, Process Biochemistry CrossRef - Intracellular pH-responsive and rituximab-conjugated mesoporous silica nanoparticles for targeted drug delivery to lymphoma B cells
Shoubing Zhou et al, 2017, Journal of Experimental & Clinical Cancer Research CrossRef - Recent Progress of Doxorubicin Nanomedicine in Hematologic Malignancies
Ying Qu et al, 2017, Nanoscience and Nanotechnology Letters CrossRef - PD-L1-targeted microbubbles loaded with docetaxel produce a synergistic effect for the treatment of lung cancer under ultrasound irradiation
Tiankuan Li et al, 2020, Biomaterials Science CrossRef - High in Vitro Anti-Tumor Efficacy of Dimeric Rituximab/Saporin-S6 Immunotoxin
Massimo Bortolotti et al, 2016, Toxins CrossRef - Targeted Microbubbles With Ultrasound Irradiation and PD-1 Inhibitor to Increase Antitumor Activity in B-cell Lymphoma
Shiya Zheng et al, 2018, Nanomedicine CrossRef - Advances and Prospects of Ultrasound Targeted Drug Delivery Systems Using Biomaterial-modified Micro/Nanobubbles for Tumor Therapy
Chen Lin et al, 2022, Current Medicinal Chemistry CrossRef - Co-delivery of rituximab targeted curcumin and imatinib nanostructured lipid carriers in non-Hodgkin lymphoma cells
Jaleh Varshosaz et al, 2021, Journal of Liposome Research CrossRef - Encapsulation of Imatinib in Targeted KIT-5 Nanoparticles for Reducing its Cardiotoxicity and Hepatotoxicity
Jaleh Varshosaz et al, 2020, Anti-Cancer Agents in Medicinal Chemistry CrossRef